Applying Recent Data Updates News Today

Experts discuss evolving practices in HER2+ breast cancer care, subcutaneous formulations, patient preferences, and resource conservation.

Experts discuss anthracycline use in HER2+ breast cancer and provide insights into how patient scenarios, heterogeneity, and neuropathy concerns shape considerations in diverse clinical situations.

Experts discuss evidence-based strategies in neoadjuvant therapy for HER2+ breast cancer and provide insights on surgery-first considerations, disease size impact, and personalized pre-operative regimens.

Experts explore neoadjuvant HER2+ breast cancer care, delve into treatment goals, predictors, and personalized approaches, and uncover insights on chemotherapy, trastuzumab, and post-op considerations.